[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [General pathology](https://durgical.com/en/general-pathology/) › [Pancreas](https://durgical.com/en/general-pathology/areas/pancreas/) › Precursors of pancreatic cancer: PanIN, IPMN, MCN

# Precursors of pancreatic cancer: PanIN, IPMN, MCN

- Process

Pancreatic cancer develops over years from small changes in duct cells, gaining one genetic hit after another.

Updated Nov 12, 2026

## Key points

- PanIN: microscopic flat or papillary mucinous lesions in ducts smaller than about five millimetres; graded low or high grade.
- KRAS activating mutation is the earliest and most frequent change (in nearly all cancers).
- CDKN2A/p16 loss next; then TP53 and SMAD4 (DPC4) loss in high-grade lesions and cancer.
- SMAD4 loss is fairly specific to pancreatic cancer and linked to widespread metastasis.
- Germline BRCA2, BRCA1, PALB2, ATM, mismatch repair genes, CDKN2A (familial melanoma) and PRSS1 raise risk.
- Years elapse between first mutations and invasion, a window for detection.

## What it is

Invasive pancreatic ductal adenocarcinoma arises from non-invasive precursors. The most common is pancreatic intraepithelial neoplasia (PanIN), a microscopic lesion of small ducts. Larger, cystic precursors are IPMN and mucinous cystic neoplasm. The progression follows a stepwise molecular model: telomere shortening and KRAS activation early, CDKN2A (p16) loss in intermediate lesions, and TP53 and SMAD4 loss late at the transition to invasive cancer.

## Step by step

- Telomere shortening in duct cells favours chromosomal instability.
- KRAS activation drives proliferation: low-grade PanIN.
- CDKN2A loss removes the p16 brake on the cell cycle.
- TP53 loss allows DNA damage to accumulate: high-grade PanIN.
- SMAD4 loss frees cells from TGF-β growth control and favours invasion.
- Invasive ductal adenocarcinoma with desmoplasia develops.

## Precursors of pancreatic ductal adenocarcinoma

| Precursor | Size and site | Key features | Molecular |
| --- | --- | --- | --- |
| PanIN | Microscopic, small ducts | Columnar mucinous epithelium, flat or papillary; low or high grade | KRAS early, then CDKN2A, TP53, SMAD4 |
| IPMN | Visible cyst in main or branch ducts | Papillary mucinous epithelium, duct communication | GNAS, KRAS, RNF43 |
| Mucinous cystic neoplasm | Cyst in body or tail, no duct connection | Mucinous epithelium over ovarian stroma | KRAS, RNF43 |

## Markers

- Loss of SMAD4 (DPC4) immunostain
- p53 overexpression or loss
- MUC1 and MUC2 (IPMN subtypes)

## Memory aid

K-R-A-S starts, p16 slows the brakes, p53 and SMAD4 finish: the four steps of the pancreatic cancer ladder.

## Test yourself

Think of the answer, then tap the question to see it.

## What is the most common precursor of pancreatic ductal adenocarcinoma?

Pancreatic intraepithelial neoplasia (PanIN), a microscopic lesion of small ducts.

## Which mutation is the earliest in the PanIN to carcinoma sequence?

An activating KRAS mutation.

## Which tumour suppressor genes are typically lost late, at the transition to invasive cancer?

TP53 and SMAD4 (DPC4).

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/general-pathology/precursors-of-pancreatic-cancer-panin-ipmn-mcn/)

[More Pathology questions →](https://durgical.com/en/practice/?f=pathology)

## Connections

## Related 6

- [Pancreatic ductal adenocarcinoma](https://durgical.com/en/general-pathology/pancreatic-ductal-adenocarcinoma/)
- [Cystic pancreatic neoplasms](https://durgical.com/en/general-pathology/cystic-pancreatic-neoplasms/)
- [Multistep carcinogenesis: the adenoma–carcinoma sequence](https://durgical.com/en/general-pathology/multistep-carcinogenesis-the-adenoma-carcinoma-sequence/)
- [Dysplasia and carcinoma in situ](https://durgical.com/en/general-pathology/dysplasia-and-carcinoma-in-situ/)
- [Oncogenes: RAS, MYC, HER2, BCR-ABL and the table to know](https://durgical.com/en/general-pathology/oncogenes-ras-myc-her2-bcr-abl-and-the-table-to-know/)
- [Tumour suppressor genes: RB, TP53, APC, BRCA and the two-hit hypothesis](https://durgical.com/en/general-pathology/tumour-suppressor-genes-rb-tp53-apc-brca-and-the-two-hit-hypothesis/)

## Related conditions 4

- [Pancreatic cancer](https://durgical.com/en/conditions/pancreatic-cancer/)
- [Hereditary breast and ovarian cancer syndrome (BRCA1/BRCA2)](https://durgical.com/en/conditions/hereditary-breast-and-ovarian-cancer-syndrome/)
- [Lynch syndrome (hereditary non-polyposis colorectal cancer)](https://durgical.com/en/conditions/lynch-syndrome/)
- [Melanoma](https://durgical.com/en/conditions/melanoma/)

[← All of general pathology](https://durgical.com/en/general-pathology/)

Educational content on the mechanisms of disease; not a diagnostic or treatment guide and no substitute for a health professional's advice. No doses are given.

Sources: [Pancreatic Cancer](https://www.ncbi.nlm.nih.gov/books/NBK518996/) (StatPearls (NCBI Bookshelf), 2024); [Pancreatic Cancer Treatment (PDQ®) - NCI](https://www.cancer.gov/types/pancreatic/hp/pancreatic-treatment-pdq) (National Cancer Institute, 2026).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/general-pathology/precursors-of-pancreatic-cancer-panin-ipmn-mcn/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/general-pathology/precursors-of-pancreatic-cancer-panin-ipmn-mcn/